Current Irish medicolegal landscape: an unsustainable trajectory

The number of outstanding clinical claims that are yet to be resolved as well as their associated estimated costs are at a record high in Ireland. By the end of 2022, the Irish government face 3875 active clinical claims which are expected to cost €3.85 billion in total. This does not account for fu...

Full description

Bibliographic Details
Main Authors: Keelin O'Donoghue, Clara Forrest, Dearbhaile C Collins, Seamus O'Reilly
Format: Article
Language:English
Published: BMJ Publishing Group 2023-09-01
Series:BMJ Open Quality
Online Access:https://bmjopenquality.bmj.com/content/12/3/e002433.full
_version_ 1797667769822478336
author Keelin O'Donoghue
Clara Forrest
Dearbhaile C Collins
Seamus O'Reilly
author_facet Keelin O'Donoghue
Clara Forrest
Dearbhaile C Collins
Seamus O'Reilly
author_sort Keelin O'Donoghue
collection DOAJ
description The number of outstanding clinical claims that are yet to be resolved as well as their associated estimated costs are at a record high in Ireland. By the end of 2022, the Irish government face 3875 active clinical claims which are expected to cost €3.85 billion in total. This does not account for future claims yet to be brought. The financial burden will be borne by the Irish healthcare system which is already facing unprecedented pressures on its services and staff. If current trends continue, the opportunity costs of the current medicolegal landscape will impact the future provision of healthcare. Aside from the financial consequences, clinical claims have numerous negative impacts on all parties involved. Gaining an understanding as to why claims and costs continue to increase relies on access to, and analysis of high-quality patient safety data, including learning from previous litigation. Addressing the causal and perpetuating factors requires efficient implementation of evidence-based recommendations through engagement with stakeholders, including the public. It is necessary to continuously assess the implementation of recommendations as well as measure their impact. This is to ensure that novel efforts from this point onwards do not suffer the same fate as many previous recommendations that, because of a lack of follow-on research, appear to go no further than the page of the report they are written. Action is required now to change the course of the currently unsustainable trajectory of the Irish medicolegal landscape.
first_indexed 2024-03-11T20:19:19Z
format Article
id doaj.art-4bf322fad9f04f5b86e99a05d239adc8
institution Directory Open Access Journal
issn 2399-6641
language English
last_indexed 2024-03-11T20:19:19Z
publishDate 2023-09-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Quality
spelling doaj.art-4bf322fad9f04f5b86e99a05d239adc82023-10-03T08:55:07ZengBMJ Publishing GroupBMJ Open Quality2399-66412023-09-0112310.1136/bmjoq-2023-002433Current Irish medicolegal landscape: an unsustainable trajectoryKeelin O'Donoghue0Clara Forrest1Dearbhaile C Collins2Seamus O'Reilly3Pregnancy Loss Research Group, University College Cork, Cork, IrelandAcademic Track Intern Programme, Intern Network Executive, School of Medicine, University College Cork, Cork, IrelandDepartment of Medical Oncology, Cork University Hospital, Cork, IrelandDepartment of Medical Oncology, Cork University Hospital, Cork, IrelandThe number of outstanding clinical claims that are yet to be resolved as well as their associated estimated costs are at a record high in Ireland. By the end of 2022, the Irish government face 3875 active clinical claims which are expected to cost €3.85 billion in total. This does not account for future claims yet to be brought. The financial burden will be borne by the Irish healthcare system which is already facing unprecedented pressures on its services and staff. If current trends continue, the opportunity costs of the current medicolegal landscape will impact the future provision of healthcare. Aside from the financial consequences, clinical claims have numerous negative impacts on all parties involved. Gaining an understanding as to why claims and costs continue to increase relies on access to, and analysis of high-quality patient safety data, including learning from previous litigation. Addressing the causal and perpetuating factors requires efficient implementation of evidence-based recommendations through engagement with stakeholders, including the public. It is necessary to continuously assess the implementation of recommendations as well as measure their impact. This is to ensure that novel efforts from this point onwards do not suffer the same fate as many previous recommendations that, because of a lack of follow-on research, appear to go no further than the page of the report they are written. Action is required now to change the course of the currently unsustainable trajectory of the Irish medicolegal landscape.https://bmjopenquality.bmj.com/content/12/3/e002433.full
spellingShingle Keelin O'Donoghue
Clara Forrest
Dearbhaile C Collins
Seamus O'Reilly
Current Irish medicolegal landscape: an unsustainable trajectory
BMJ Open Quality
title Current Irish medicolegal landscape: an unsustainable trajectory
title_full Current Irish medicolegal landscape: an unsustainable trajectory
title_fullStr Current Irish medicolegal landscape: an unsustainable trajectory
title_full_unstemmed Current Irish medicolegal landscape: an unsustainable trajectory
title_short Current Irish medicolegal landscape: an unsustainable trajectory
title_sort current irish medicolegal landscape an unsustainable trajectory
url https://bmjopenquality.bmj.com/content/12/3/e002433.full
work_keys_str_mv AT keelinodonoghue currentirishmedicolegallandscapeanunsustainabletrajectory
AT claraforrest currentirishmedicolegallandscapeanunsustainabletrajectory
AT dearbhaileccollins currentirishmedicolegallandscapeanunsustainabletrajectory
AT seamusoreilly currentirishmedicolegallandscapeanunsustainabletrajectory